Categories: News

Enovis™, Formerly Branded DJO®, Introduces Arsenal Ankle Plating System™

A comprehensive ankle plating portfolio, designed with the proven technology of Arsenal Foot Plating System, expands offerings to address both tri-malleolar and intra-articular fracture patterns

WILMINGTON, Del.–(BUSINESS WIRE)–DJO® is now part of the Enovis™ family.* Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System™. This system consists of 37 anatomically designed plates throughout nine plate families, offering a plating solution for any ankle fracture.


The Arsenal Ankle Plating System is the latest addition to Enovis’ suite of foot and ankle products and an expansion of Arsenal Foot Plating System, leveraging its history of proven results and pioneering technology.

“I am excited to see the technological advancements and trusted results from the Arsenal Foot Plating system applied to a broader set of indications throughout the ankle,” stated Matthew Herring, MD. “The plates are stout where it matters and sleek where needed, which makes a difference when treating complex ankle and distal tibia fractures in the OR.”

The variable angle locking technology, allowing a 60° cone of angulation, multi-lock functionality, accepting repeatable lock and relock of screw to plate interface, and dual lead screws that the Arsenal Ankle Plating System offers, makes for a powerful combination of patented and innovative solutions addressing all types of fracture personalities.

“Our Arsenal product line was created to disrupt existing technology,” said Gary Justak, President and General Manager of Enovis Foot & Ankle. “In addition to the standard ankle fracture plating options available today, this system features multiple solutions for malleoli fractures including a modernized spin of the proven AO technique of tension band wiring. These are just a couple of reasons why we are proud to introduce this system as we continue our growth journey in the Foot & Ankle market.”

Read more about Arsenal Ankle Plating System here.

DCN 22-0158

Dr. Herring is a paid consultant at DJO.

ABOUT ENOVIS™

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com/DJO.

* DJO Foot and Ankle (“DJO”) is excited to announce that its parent company, Colfax Corporation, has changed its name to Enovis Corporation. As part of our rebranding initiative, DJO is now part of the Enovis family. DJO continues to be wholly owned by Enovis Corporation, and DJO will continue to operate as an active legal entity under the ownership of Enovis Corporation.

Contacts

Megan Foltz

Megan.foltz@enovis.com
609.680.0996

Staff

Recent Posts

Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference

SEATTLE, WA / ACCESSWIRE / March 18, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage…

4 mins ago

BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps

VANCOUVER, BC / ACCESSWIRE / March 18, 2024 / BioNxt Solutions Inc. ("BioNxt" or the…

4 mins ago

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

21 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago